Meta-analysis of randomized controlled trials on the benefits and risks of using cisapride for the treatment of gastroesophageal reflux in children

Jacqueline R Dalby-Payne, Anne M Morris, Jonathan C. Craig

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract



Background and Aim: Gastroesophageal reflux is a common problem in infancy. Cisapride is a commonly used therapy for gastroesophageal reflux in children. In view of recent concern regarding adverse effects this study aims to evaluate the benefits and risks of cisapride for the treatment of gastroesophageal reflux in children.

Methods: A meta‐analysis of randomized controlled trials of cisapride using a random‐effects model.

Results: Ten trials involving 415 children were identified. There was no evidence of a significant reduction in vomiting severity with cisapride as measured by a clinical score (five trials, standardized weighted mean difference −0.18; 95% confidence interval (CI) −0.51 to 0.15). Twenty‐four‐hour esophageal pH monitoring data showed the mean reflux index was significantly lower in the children treated with cisapride compared with controls (five trials, weighted mean difference −6.24; 95% CI −8.81 to −3.67). With cisapride treatment, there was no reduction in the mean number of reflux episodes lasting greater than 5 min (three trials, weighted mean difference −0.72; 95% CI −1.92 to 0.47) or in the number of children with esophagitis at final follow up compared with baseline (two trials, relative risk 0.80; 95% CI 0.40 to 1.61). There was no significant difference in reported side‐effects or adverse events (six trials, relative risk 1.16; 95% CI 0.95 to 1.41).

Conclusions No clinically important benefits of cisapride in children with gastroesophageal reflux have been demonstrated. Nor was there any evidence of adverse or harmful events.
Original languageEnglish
Pages (from-to)196-202
Number of pages7
JournalJournal of Gastroenterology and Hepatology
Volume18
Issue number2
DOIs
Publication statusPublished - 24 Jan 2003
Externally publishedYes

Keywords

  • Gastro-esophageal reflux
  • cisapride
  • Risk assessment

Fingerprint Dive into the research topics of 'Meta-analysis of randomized controlled trials on the benefits and risks of using cisapride for the treatment of gastroesophageal reflux in children'. Together they form a unique fingerprint.

  • Cite this